Impact of Uterine Leiomyoma Location on Uterine Artery Doppler Velocimetry
NCT ID: NCT07186257
Last Updated: 2025-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
185 participants
OBSERVATIONAL
2024-10-01
2025-06-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Results: Mean values of PI, RI and S/D ratio were significantly lower in intramural myoma subgroup (p\<0,01). The doppler parameters were significantly higher for submucousal myoma compared to intramural and subserous myoma groups (p\<0,01) while there was no significant difference with control group. The impact of uterin leiomyoma location on uterin arter doppler findings were not altered by the effects of demographical features, age, BMI or history of c-section. The increased volumes of both uterus and myoma negatively correlated with the doppler indices while the history of c-section had a positive correlation with the doppler findings. The complaints of the patients at admission showed no effect on the doppler parameters.
Conclusion: The uterin leiomyoma location has been showed to be significant factor on uterin doppler velocimetry. The leiomyomas with intramural component significantly decreased the resistance in uterine artery. Further research is required to fully understand the underlying mechanism.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Impact of Myomectomy on Uterine Artery Doppler Velocimetry Findings
NCT07343765
Measurement of Fibroid Volume and 2D, 3D US
NCT02638688
Prevelance of Uterine Vein and Uterine Vein System Variations
NCT06520969
Sonographic Features of Fibroids Before and During Non-surgical Therapy and/or Expectant Management
NCT05741671
Complications in Singleton Pregnancies Following Previous Cesarean Myomectomy
NCT04766567
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
submucous leiomyoma
patients who are diagnosed with submucous leiomyoma
No interventions assigned to this group
intramural leiomyoma
patients who are diagnosed with intramural leiomyoma
No interventions assigned to this group
subserous leiomyoma
patients who are diagnosed with subserous leiomyoma
No interventions assigned to this group
control
patients in the control group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* accepting the transvaginal ultrasound examination and having no impediment of having transvaginal ultrasound examination
* premenopausal status
* giving verbal and written consent to enroll
* being in the follicular phase of the menstrual cycle
Exclusion Criteria
* pregnancy or postpartum status
* postmenopausal status
* being virgin
* not accepting the transvaginal ultrasound examination or having an impeding condition
* having a disease causing circulaiton abnormalities, cardiac diseases, or other comorbidities effecting circulation
* diagnosed diabetes
* taking any of the hormonal drugs (such as oral contraceptives, levonorgestrel realisng intrauterine devices)
* diagnosed with any other gyneoclogical pathologies ( adenomyosis, endometriosis, adnexial masses, gynecologic malignancies, pelvic inflammatory diseases etc. )
* being in the phases of menstrual cycle other than follicular phase
* diagnosis with type 2-5 and type 8 leiomyoma uteri according to the FIGO classification
* having multiple uterine leiomyomas
* having a uterine leiomyoma larger than 500cm3
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
İlke Esin Aydıner
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bakırköy Dr Sadi Konuk Eğitim ve Araştırma Hastanesi
Istanbul, bakırköy, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-11-17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.